Tofacitinib, a novel JAK3 inhibitor, as a potential cause of distal symmetric polyneuropathy

J Eur Acad Dermatol Venereol. 2016 Jun;30(6):1066-7. doi: 10.1111/jdv.13114. Epub 2015 Mar 19.

Authors

C Zeidler¹, A von Köckritz¹, T A Luger¹, S Ständer¹, I W Husstedt², A Tsianakas¹

Affiliations

¹ Dermatology, University Hospital Münster, Münster, Germany.
² Neurology, University Hospital Münster, Münster, Germany.

PMID: 25787234
DOI: 10.1111/jdv.13114

No abstract available

Publication types

Letter

MeSH terms

Adult
Humans
Male
Piperidines / therapeutic use*
Psoriasis / drug therapy*
Pyrimidines / therapeutic use*
Pyrroles / therapeutic use*

Substances

Piperidines
Pyrimidines
Pyrroles
tofacitinib